Cochrane Reviews: Malaria

Research in 1900 suggested house modifications may reduce malaria transmission. A previous version of this review concluded that house screening may be effective in reducing malaria. This update includes data from five new studies.

Authors of this updated Cochrane review concluded that pyronaridine-artesunate is as effective as other antimalarials and is safe in treating uncomplicated cases of an important type of malaria (Plasmodium falciparum). 

Treating everyone for malaria: does it eliminate the disease? Some policy experts recommend giving antimalarial drugs to everyone living in a malarious area at the same time to accelerate elimination of the disease, but this is controversial.

Pyrethroid + PBO bed nets reduce malaria infection in areas of high pyrethroid resistance

Treating uncomplicated malaria in children: do child‐friendly formulations of medicines work better than usual tablet formulations?

This review evaluates the  effects of house modifications on malaria disease and transmission.

Primaquine to cure people with Plasmodium vivax malaria: comparing dosing schedules

Evaluating whether larviciding with chemical or microbial insecticides prevents malaria transmission.

Artemether injection for treating people with severe malaria

The aim of this Cochrane Review was to find out if the antimalarial drug pyronaridine‐artesunate is effective and safe to treat uncomplicated cases of an important type of malaria (P falciparum). We collected and analysed all relevant studies to answer this question and found 10 studies.

The aim of this review update was to evaluate the available evidence and find out whether ITNs continue to be effective at controlling the disease. Cochrane researchers collected and analysed relevant studies and assessed the overall certainty of the evidence.